Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 5 | 2020 | 193 | 0.430 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 67 | 0.350 |
Why?
|
| Hypertension | 6 | 2014 | 835 | 0.270 |
Why?
|
| Quality of Life | 3 | 2014 | 616 | 0.170 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2012 | 65 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 4 | 2010 | 242 | 0.160 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 420 | 0.150 |
Why?
|
| Kidney | 3 | 2012 | 372 | 0.130 |
Why?
|
| Glomerulonephritis | 1 | 1995 | 13 | 0.110 |
Why?
|
| Anemia, Sickle Cell | 1 | 1995 | 187 | 0.100 |
Why?
|
| Endothelins | 1 | 2012 | 7 | 0.100 |
Why?
|
| Magnesium Sulfate | 1 | 2012 | 5 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2008 | 172 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2012 | 40 | 0.090 |
Why?
|
| Health Status | 2 | 2014 | 442 | 0.090 |
Why?
|
| Aspirin | 1 | 2012 | 89 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 146 | 0.090 |
Why?
|
| Aged | 10 | 2020 | 8214 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 491 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2012 | 386 | 0.070 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 16 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 78 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2010 | 666 | 0.070 |
Why?
|
| Antioxidants | 1 | 2012 | 443 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2008 | 68 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 287 | 0.070 |
Why?
|
| Female | 10 | 2014 | 24698 | 0.070 |
Why?
|
| Humans | 15 | 2020 | 43102 | 0.060 |
Why?
|
| Creatine | 1 | 2006 | 10 | 0.060 |
Why?
|
| Inflammation | 1 | 2012 | 758 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2014 | 1759 | 0.060 |
Why?
|
| Pregnancy | 1 | 2012 | 1772 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 236 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2006 | 147 | 0.060 |
Why?
|
| Middle Aged | 9 | 2014 | 12222 | 0.050 |
Why?
|
| Adult | 8 | 2020 | 13872 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 54 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 55 | 0.050 |
Why?
|
| Male | 12 | 2014 | 23409 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2003 | 40 | 0.050 |
Why?
|
| Hypernatremia | 1 | 2002 | 10 | 0.050 |
Why?
|
| Patient Selection | 1 | 2004 | 205 | 0.050 |
Why?
|
| Albuminuria | 2 | 2010 | 78 | 0.050 |
Why?
|
| Creatinine | 2 | 2014 | 102 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2003 | 80 | 0.050 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2001 | 2 | 0.040 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2001 | 6 | 0.040 |
Why?
|
| Spirituality | 1 | 2020 | 53 | 0.040 |
Why?
|
| Religion | 1 | 2020 | 90 | 0.040 |
Why?
|
| Disease Progression | 2 | 2014 | 667 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 1998 | 12 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 1998 | 102 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 574 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1063 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 1604 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2011 | 3156 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 1995 | 32 | 0.030 |
Why?
|
| Risk Factors | 2 | 2006 | 3994 | 0.020 |
Why?
|
| Systole | 1 | 2012 | 67 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 518 | 0.020 |
Why?
|
| Employment | 1 | 2011 | 86 | 0.020 |
Why?
|
| Income | 1 | 2011 | 160 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 41 | 0.020 |
Why?
|
| Adolescent | 3 | 2008 | 6081 | 0.020 |
Why?
|
| Social Support | 1 | 2011 | 445 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 719 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1081 | 0.010 |
Why?
|
| Depression | 1 | 2011 | 863 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1612 | 0.010 |
Why?
|
| Gallium Isotopes | 1 | 2003 | 1 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 29 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 177 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 238 | 0.010 |
Why?
|
| Research Design | 1 | 2004 | 385 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 374 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 245 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 135 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 490 | 0.010 |
Why?
|
| United States | 1 | 2011 | 5205 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 638 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 587 | 0.010 |
Why?
|
| Comorbidity | 1 | 2002 | 737 | 0.010 |
Why?
|
| Sex Factors | 1 | 2002 | 1028 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2002 | 1234 | 0.010 |
Why?
|
| Mental Health | 1 | 2002 | 385 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 5080 | 0.010 |
Why?
|